Cargando…

Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report

Hepatocellular carcinoma (HCC) is a highly aggressive malignant tumor. The survival of advanced HCC is very poor. In this case study, we describe the treatment of a 69-year-old woman diagnosed with massive hepatocellular carcinoma, the use of lenvatinib in combination with nivolumab injection in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xin, Zhang, Yazhou, Zhang, Nu, Ge, Yongsheng, Jia, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752163/ https://www.ncbi.nlm.nih.gov/pubmed/31686845 http://dx.doi.org/10.2147/OTT.S217123

Ejemplares similares

Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
por: Ohya, Yuki, et al.
Publicado: (2020)

Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
por: Wu, Wen-Chi, et al.
Publicado: (2022)

The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma
por: Shen, Ying-Hao, et al.
Publicado: (2022)

Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy
por: Dai, Mu-Gen, et al.
Publicado: (2023)

Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
por: Chen, Hao, et al.
Publicado: (2020)

Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report
por: Takahashi, Kazuhiro, et al.
Publicado: (2021)

A case of Vp4 hepatocellular carcinoma with tumor thrombosis extending into the confluence of the splenic/portal vein achieved a good prognosis with emergent hepatectomy and postoperative adjuvant therapy with lenvatinib
por: Kato, Hiroyuki, et al.
Publicado: (2022)

Laparoscopic Right Hepatectomy Via an Anterior Approach for Hepatocellular Carcinoma
por: Chen, Huan Wei, et al.
Publicado: (2018)

Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
por: Tao, Meng, et al.
Publicado: (2023)

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
por: Ouyang, Jingzhong, et al.
Publicado: (2023)

Application Effect of ICG Fluorescence Real-Time Imaging Technology in Laparoscopic Hepatectomy
por: Chen, Hao, et al.
Publicado: (2022)

Duodenoportal fistula caused by peptic ulcer after extended right hepatectomy for hilar cholangiocarcinoma
por: Kinoshita, Hiroyuki, et al.
Publicado: (2006)

Simple and sure methodology for massive hepatectomy in the mouse
por: Hori, Tomohide, et al.
Publicado: (2011)

Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study
por: Jia, Meng, et al.
Publicado: (2022)

The Effects of Ursodeoxycholic Acid Pretreatment in an Experimental Setting of Extended Hepatectomy: A Feasibility Study
por: Paspala, Anna, et al.
Publicado: (2020)

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Right hepatectomy for combined primary neuroendocrine and hepatocellular carcinoma. A case report()
por: Aboelenen, Ahmed, et al.
Publicado: (2013)

Total robotic right hepatectomy for multifocal hepatocellular carcinoma using vessel sealer
por: Varshney, Peeyush, et al.
Publicado: (2023)

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma
por: He, Min-Ke, et al.
Publicado: (2021)

Is laparoscopic hepatectomy superior to open hepatectomy for hepatocellular carcinoma?
por: Zhong, Jian-Hong, et al.
Publicado: (2017)

Giant liver teratoma with gliosis peritonei treated by right extended hepatectomy: Overview and case report
por: García-Ríos, Luis Enrique, et al.
Publicado: (2021)

Lenvatinib for Hepatocellular Carcinoma: A Literature Review
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
por: Lee, Matthew Man Pok, et al.
Publicado: (2023)

Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients
por: Zou, Jixue, et al.
Publicado: (2022)

Sorafenib, Lenvatinib, or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
por: Zhao, Shu, et al.
Publicado: (2022)

Location of Hemangioma is an Individual Risk Factor for Massive Bleeding in Laparoscopic Hepatectomy
por: Si, Shuang, et al.
Publicado: (2021)

Minimally Invasive Donors Right Hepatectomy versus Open Donors Right Hepatectomy: A Meta-Analysis
por: Mu, Chunyang, et al.
Publicado: (2023)

Feasibility of Right Upper Transversal Hepatectomy in the Absence of an Inferior Right Hepatic Vein: New Insights regarding This Complex Procedure
por: Makdissi, Fabio Ferrari, et al.
Publicado: (2021)

Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC
por: Wang, Yunchao, et al.
Publicado: (2023)

Upregulation of microfibrillar-associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma
por: Zhang, Nu, et al.
Publicado: (2021)

A Single Center Experience for a Feasibility of Totally Laparoscopic Living Donor Right Hepatectomy
por: Park, Min-Su
Publicado: (2019)

A Single Center Experience for a Feasibility of Totally Laparoscopic Living Donor Right Hepatectomy
por: Lee, Soo Kyung, et al.
Publicado: (2019)

Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway
por: Hao, Jianwen, et al.
Publicado: (2021)

Transcriptome sequencing and metabolome analysis reveal the metabolic reprogramming of partial hepatectomy and extended hepatectomy
por: Li, Zeyuan, et al.
Publicado: (2023)

Technique of robotic right donor hepatectomy
por: Chandran, Biju, et al.
Publicado: (2022)

Simplifying minimally invasive right hepatectomy
por: Nevermann, Nora, et al.
Publicado: (2023)

The Preference for Anterior Approach Major Hepatectomy: Experience Over 3 Decades and a Propensity Score-Matching Analysis in Right Hepatectomy for Hepatocellular Carcinoma
por: Chan, Kun-Ming, et al.
Publicado: (2015)

Concomitant Hepatectomy and Atrial Thrombectomy under Cardiopulmonary Bypass versus Staged Hepatectomy in the Treatment for Hepatocellular Carcinoma with Large Right Atrial Tumor Thrombi
por: Chao, Wen-Shan, et al.
Publicado: (2022)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
por: Personeni, Nicola, et al.
Publicado: (2019)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dpho39osn907qubmkdct7utgac